Search research articles
Contact Us
Filters
Showing results (151-160 of 220) with videos related to
Page
of 22
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 25, 2022
The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients
Kenneth Chappell, Romain Colle, Abd El Kader Ait Tayeb, et al.
Journal of Affective Disorders
|
February 15, 2020
Severe insomnia is associated with metabolic syndrome in women over 50 years with major depression treated in psychiatry settings: a METADAP report
Jean-François Costemale-Lacoste, Khalil El Asmar, Adrien Rigal, et al.
Neuropsychobiology
|
September 5, 2025
Exploring Blood Glutamate as a Diagnostic Biomarker for Major Depressive Episodes in a context of Major Depressive Disorder
Khalil El Asmar, Tala El Ghoul, Romain Colle, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
Benjamin Portal, Flora Vasile, Jonathan Zapata, et al.
Brain Stimulation
|
March 13, 2021
Efficacy and safety of adjunctive vagus nerve stimulation in the treatment of resistant depression with psychotic features: A case report
Romain Colle, Abd El Kader Ait Tayeb, Lauriane Delhay, et al.
Fundamental & Clinical Pharmacology
|
May 10, 2023
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects
Julie Doan, Céline Defaix, Indira Mendez-David, et al.
NPJ Biofilms and Microbiomes
|
February 4, 2026
Prucalopride, a serotonin type 4 receptor agonist, induces fast anxiolytic/antidepressant effects and concomitant changes in the gut microbiota
Sofia Cussotto, Salma R Abdennebi, Isabelle Etting, et al.
Psychiatry Research
|
October 28, 2016
Tobacco use is associated with increased plasma BDNF levels in depressed patients
Romain Colle, Séverine Trabado, Samuel Rotenberg, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression
Cassandre Corvo, Indira Mendez-David, Sébastien Goutal, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 21, 2022
Hospitalization for COVID-19 is associated with a higher risk of subsequent hospitalization for psychiatric disorders: A French nationwide longitudinal study comparing hospitalizations for COVID-19 and for other reasons
Valentina Decio, Philippe Pirard, Baptiste Pignon, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 220) with videos related to
Sort By:
Page
of 22
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 25, 2022
The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients
Kenneth Chappell, Romain Colle, Abd El Kader Ait Tayeb, et al.
Journal of Affective Disorders
|
February 15, 2020
Severe insomnia is associated with metabolic syndrome in women over 50 years with major depression treated in psychiatry settings: a METADAP report
Jean-François Costemale-Lacoste, Khalil El Asmar, Adrien Rigal, et al.
Neuropsychobiology
|
September 5, 2025
Exploring Blood Glutamate as a Diagnostic Biomarker for Major Depressive Episodes in a context of Major Depressive Disorder
Khalil El Asmar, Tala El Ghoul, Romain Colle, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
Benjamin Portal, Flora Vasile, Jonathan Zapata, et al.
Brain Stimulation
|
March 13, 2021
Efficacy and safety of adjunctive vagus nerve stimulation in the treatment of resistant depression with psychotic features: A case report
Romain Colle, Abd El Kader Ait Tayeb, Lauriane Delhay, et al.
Fundamental & Clinical Pharmacology
|
May 10, 2023
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects
Julie Doan, Céline Defaix, Indira Mendez-David, et al.
NPJ Biofilms and Microbiomes
|
February 4, 2026
Prucalopride, a serotonin type 4 receptor agonist, induces fast anxiolytic/antidepressant effects and concomitant changes in the gut microbiota
Sofia Cussotto, Salma R Abdennebi, Isabelle Etting, et al.
Psychiatry Research
|
October 28, 2016
Tobacco use is associated with increased plasma BDNF levels in depressed patients
Romain Colle, Séverine Trabado, Samuel Rotenberg, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression
Cassandre Corvo, Indira Mendez-David, Sébastien Goutal, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 21, 2022
Hospitalization for COVID-19 is associated with a higher risk of subsequent hospitalization for psychiatric disorders: A French nationwide longitudinal study comparing hospitalizations for COVID-19 and for other reasons
Valentina Decio, Philippe Pirard, Baptiste Pignon, et al.
Page
of 22